| Literature DB >> 29759095 |
Alfonso Martínez-García1, Carolina Michel-Macías2, Guadalupe Cordero-González2, Karla I Escamilla-Sánchez2, Mónica Aguinaga-Ríos3, Alejandra Coronado-Zarco2, Jorge A Cardona-Pérez2.
Abstract
IntroductionIntracardiac rhabdomyomas can cause severe ventricular dysfunction and outflow tract obstruction.Case reportA term newborn infant with antenatal diagnosis of giant left ventricle rhabdomyoma presented with cardiac failure and duct-dependent systemic circulation after birth. She was treated successfully with everolimus, showing decrease in tumour size and improvement in left ventricular ejection fraction.DiscussionTumour regression rate was 0.32 cm2/day and improved to 0.80 cm2/day with the use of everolimus. Herein we report a newborn with inoperable giant left ventricular cardiac rhabdomyoma and significant regression of the tumour. To our knowledge, this is the largest left ventricular rhabdomyoma reported. A review of the literature was undertaken for comparison.Entities:
Keywords: Rhabdomyoma; everolimus; newborn; sirolimus
Mesh:
Substances:
Year: 2018 PMID: 29759095 DOI: 10.1017/S1047951118000598
Source DB: PubMed Journal: Cardiol Young ISSN: 1047-9511 Impact factor: 1.093